GLENVIEW – State Senator Laura Fine joined the Illinois Department of Commerce and Economic Opportunity to announce $15 million in funding for the Job Training and Economic Development program, including more than $366,000 for the Youth Job Center in Evanston.

“The JTED program is a reflection of the plans we have to support underrepresented and unemployed individuals in the workforce so all Illinoisans have access to the tools they need to succeed in their professional and personal lives,” said Fine (D-Glenview). “I am pleased to see funding benefit the Youth Job Center in my district, and I look forward to expanding workforce possibilities for all.”

This is the second round of funding from the JTED program, awarding over $15 million to 33 organizations across Illinois. The Job Training and Economic Development program provides workforce training and wraparound services to help bolster equitable workforce recovery for Illinoisans struggling to gain meaningful employment. Funds from this program aim to address the economic impacts experienced by employers and individuals who are underemployed, unemployed or underrepresented who have one or more barriers to employment that are identified as risk factors.

GLENVIEW – Legislation sponsored by State Senator Laura Fine and State Representative Jennifer Gong-Gershowitz, aimed at addressing critical gaps in Illinois' health insurance, has been signed into law by the governor. The new law guarantees individuals with major jaw injuries including those caused by cancer, access to essential medical treatments without the fear of insurance denials.

“This law closes a major loophole for patients requiring necessary medical treatments for a life-threatening disease. It ensures that in a time of crisis, no one has to experience financial roadblocks to receiving medical care,” said Fine (D-Glenview). “This new law is a common sense solution resulting from the collaboration between the Illinois State Dental Society and the Insurance industry.  As a result, cancer patients requiring jaw surgery will have coverage for the care they need.”

The legislation started when an Illinois resident undergoing treatment for Jaw cancer required extensive reconstructive surgery and dental implants to restore basic functions like eating and speaking. However, when this patient turned to their insurance provider for help, they were met with denial. The insurance company labeled the dental implants as "cosmetic," refusing to cover the cost, despite the critical and obvious role these implants played in the patient's recovery.

SPRINGFIELD – To protect state employees from unexpected opioid overdoses in the workplace, a new law championed by State Senator Laura Fine aims to provide protection through the availability of lifesaving resources.

“The opioid crisis can impact any community, and we need to ensure no one is left without necessary resources to save a life,” said Fine (D-Glenview). “This law supports our state’s workforce by expanding access to opioid antagonists to trained workers.”

This law allows opioid antagonists to be made available at state agencies once employees are trained on how to properly administer the medication. The law also protects employees from civil liability should they administer the overdose reversal medication.

SPRINGFIELD –   In an effort to protect individuals from certain illnesses, State Senator Laura Fine championed a law to require insurance coverage for the administration of yearly vaccines.

“Choosing to be vaccinated for COVID or the common flu is a personal decision that allows an individual to look after their own wellbeing,” said Fine (D-Glenview). “Patients seeking to protect their health are now able to do so without the added barrier vaccination administration costs can present.”

Although there may not be a cost for the vaccine, there are times when patients are required to pay the vaccine administration fee. Under SB 2744, all state-regulated insurance plans would be required to cover the administration fees associated with COVID-19 vaccines, flu vaccines and respiratory syncytial virus (RSV) vaccines, beginning Jan. 1, 2026.